Medication Assisted Treatment

Opioid Use Disorders and Overdoses have turned into a national health crisis, and more effective and life-saving public health responses are imperative to curb this growing epidemic. Medication-Assisted Treatment has a profound role in the battle of the OUD epidemic. It is important to learn how to maximize MATs like Vivitrol, Narcan, Naltrexone, etc. and their efficacy in the context of an all-encompassing treatment approach.

Dr. Mark Gold & Dr. Brian Fuerhlein Discuss Medication-Assisted Treatment in Opiate Use Disorder & Substance Use Disorder

Opioid use and addiction have quickly transformed into a national health crisis of epidemic proportions, and the epidemic demands innovative scientific strategies and interventions.

The United States is the world’s largest consumer of opioids. The non-medicinal use of and addiction to opioids, particularly prescription pain relievers, heroin, and synthetic opioids like fentanyl, have escalated into a national epidemic adversely affecting public health, social welfare, and economic progress.

Every day, more than 115 people in the United States die due to overdosing on opioids. In 2016, 42,249 Americans fatally overdosed on an opioid. Of the 20.5 million Americans 12 or older who had a substance use disorder in 2015, 2 million had a substance use disorder involving prescription pain relievers, and 591,000 had a substance use disorder involving heroin.

In addition to Medication-Assisted Treatment (MAT), office-based opioid treatments and ambulatory detoxification, timely identification and treatment of co-existing trauma, sexually transmitted diseases, infections, cardiovascular and other common psychological co-occurring disorders have to take its due position in recovery.

While we often focus on reducing overdose and reversing those overdoses that occur, many overdoses are patients with OUDs who are not in treatment. Medication Addiction Treatment like Buprenorphine, Suboxone, Naloxone, and opioid use disorder treatment programs are essential parts of our response to overdose initiatives.

Deaths from overdose are increasing during the COVID-19 crisis as EMTs, Emergency Rooms, and General Hospitals are inundated with COVID cases, and people with OUDs are staying away. 47,600 people died from drug overdoses involving opioids in 2017.

2020 Annual National Survey on Drug Use and Health – NSDUH Review

Guy in mountains thinking about Substance Use Disorder Recovery On September 14, 2020, the Substance Abuse and Mental Health Services Administration reported the annual National Survey on Drug Use and Health: OUD decreases, mental illness increased. What are the main findings of the NSDUH (National Survey on Drug Use and Health) survey, and what can we learn? First of all, what is the NSDUH, [...]
Read More

Saving Lives with Naltrexone – Vivitrol: A Crucial Defense in OUD

Doctor thinking about moving Methadone to Primary Care Opioid use disorder (OUD) is a chronic, life-threatening, relapsing condition, often associated with legal, interpersonal, and employment problems. FDA approved safe and effective medications for OUD are methadone (a full opioid agonist), Buprenorphine (a partial agonist), Naltrexone, and Naltrexone-long-acting injectable or Vivitrol (opioid antagonists). Methadone and Buprenorphine suppress opioid withdrawal symptoms by being other opioid [...]
Read More

Naltrexone and Injectable Naltrexone (Vivitrol) for Opioid Use Disorders (OUDs)

Man's face with beard The United States is a resurgent national opioid use and overdose epidemic. Physicians are encouraged to treat opioid-use disorders (OUDs), learn about addiction medicine, and help treat OUD patients with the three Food and Drug Administration approved medications (methadone, buprenorphine, and Naltrexone). There is little disagreement at this point that these medications are safe and [...]
Read More

Buprenorphine, Suboxone and the Treatment of Opioid Use Disorder (OUD) in 2020 – Part 2

Doctor doing Research on medical marijuana Contributor: Mark S. Gold, M.D., Professor, Washington University School of Medicine – Department of Psychiatry Three Phases of Buprenorphine Treatment: The Induction Phase is the medical initiation of buprenorphine treatment. Phase 1 usually begins with a visit to a qualified physician’s office or certified OTP using approved buprenorphine products. Buprenorphine is administered to a person with [...]
Read More

Buprenorphine, Suboxone and the Treatment of Opioid Use Disorder (OUD) in 2020 – Part 1

Doctor in Research Laboratory working on the Future of Marijuana Contributor: Mark S. Gold, M.D., Professor, Washington University School of Medicine – Department of Psychiatry Introduction Opioid use disorder (OUD) is a chronic, relapsing, and acquired disease. Opioid use stimulates it’s own taking until loss of control and continued use cause numerous consequences. OUD is often associated with loss of life, employment, relationships, and health. We [...]
Read More